Hope, confusion surround quest for early ovarian cancer test

A screening method that its maker says would allow for early treatment is already on the market, without FDA approval and facing scrutiny. Does a test that promises to detect ovarian cancer sooner really do so? Could other tests nearing the market prolong survival by getting patients the right care faster?

Read the whole article on LA Times - Health

More from LA Times - Health